Literature DB >> 3805772

A case-control study of the clinical diagnosis and course of Lassa fever.

J B McCormick, I J King, P A Webb, K M Johnson, R O'Sullivan, E S Smith, S Trippel, T C Tong.   

Abstract

A prospective case-control study of Lassa fever was established in Sierra Leone to measure the frequency and case-fatality ratio of Lassa fever among febrile hospital admissions and to better delineate the clinical diagnosis and course of this disease. Lassa fever was responsible for 10%-16% of all adult medical admissions and for approximately 30% of adult deaths in the two hospitals studied. The case-fatality ratio for 441 hospitalized patients was 16.5%. We found the best predictor of Lassa fever to be the combination of fever, pharyngitis, retrosternal pain, and proteinuria (predictive value together, .81); of outcome, the best predictor was the combination of fever, sore throat, and vomiting (relative risk of death, 5.5). Complications included mucosal bleeding (17%), bilateral or unilateral eighth-nerve deafness (4%), and pleural (3%) or pericardial (2%) effusion. Lassa fever is endemic in this area and is a more-common cause of hospital admission and death than has previously been described; this disease must be considered when diagnosing febrile illness in West Africa.

Entities:  

Mesh:

Year:  1987        PMID: 3805772     DOI: 10.1093/infdis/155.3.445

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  131 in total

1.  Identification of a novel consensus sequence at the cleavage site of the Lassa virus glycoprotein.

Authors:  O Lenz; J ter Meulen; H Feldmann; H D Klenk; W Garten
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation.

Authors:  D G Bausch; P E Rollin; A H Demby; M Coulibaly; J Kanu; A S Conteh; K D Wagoner; L K McMullan; M D Bowen; C J Peters; T G Ksiazek
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

3.  The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P.

Authors:  O Lenz; J ter Meulen; H D Klenk; N G Seidah; W Garten
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

4.  Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus).

Authors:  David X Liu; Donna L Perry; Lisa Evans DeWald; Yingyun Cai; Katie R Hagen; Timothy K Cooper; Louis M Huzella; Randy Hart; Amanda Bonilla; John G Bernbaum; Krisztina B Janosko; Ricky Adams; Reed F Johnson; Jens H Kuhn; Matthias J Schnell; Ian Crozier; Peter B Jahrling; Juan C de la Torre
Journal:  J Infect Dis       Date:  2019-05-05       Impact factor: 5.226

Review 5.  Lassa fever: epidemiology, clinical features, and social consequences.

Authors:  J Kay Richmond; Deborah J Baglole
Journal:  BMJ       Date:  2003-11-29

6.  Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor.

Authors:  Robert Eichler; Oliver Lenz; Thomas Strecker; Markus Eickmann; Hans-Dieter Klenk; Wolfgang Garten
Journal:  EMBO Rep       Date:  2003-10-10       Impact factor: 8.807

7.  Improved detection of Lassa virus by reverse transcription-PCR targeting the 5' region of S RNA.

Authors:  Stephan Olschläger; Michaela Lelke; Petra Emmerich; Marcus Panning; Christian Drosten; Meike Hass; Danny Asogun; Deborah Ehichioya; Sunday Omilabu; Stephan Günther
Journal:  J Clin Microbiol       Date:  2010-03-29       Impact factor: 5.948

8.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

9.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

10.  Mutational evidence for a structural model of the Lassa virus RNA polymerase domain and identification of two residues, Gly1394 and Asp1395, that are critical for transcription but not replication of the genome.

Authors:  Meike Hass; Michaela Lelke; Carola Busch; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.